InsidersTradesSigma
Total declarations
Companies
▲ Purchases (8 ops.)
▼ Sales (2 ops.)
Insider track record
CEODisclosed buys
8
Disclosed sells
2
T+90 hit rate
0%
T+90 mean return
-9.8%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Green James W, Chairman & CEO. Director active across 3 companies, notably HARVARD BIOSCIENCE INC. Cumulatively, 31 disclosures have been published. Split: 8 buys · 2 sells. Total volume traded: €937k. Activity tracked since 18 May 2021. The latest transaction was filed on 15 August 2025 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Green James W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations31 total
49,048 shares0Common StockSEC:0001104659-25-080209:0
38,413 shares@ US$0.68861.6% of flowCommon StockSEC:0001104659-25-026702:0
145,365 shares0Common StockSEC:0000921895-25-000025:0
56,915 shares@ US$1.987.3% of flowCommon StockSEC:0000921895-24-003052:0
10,000 shares@ US$2.911.8% of flowCommon StockSEC:0000921895-24-001418:0
Canonical exit: 11 Sept 2024 (T+90)
20,000 shares@ US$3.073.8% of flowCommon StockSEC:0000921895-24-001362:0
Canonical exit: 4 Sept 2024 (T+90)
214,797 shares0Common StockSEC:0001193805-24-000333:0
24,187 shares@ US$5.357.9% of flowCommon StockSEC:0000921895-24-000043:0
25,000 shares@ US$4.386.8% of flowCommon StockSEC:0000921895-23-002050:0
Canonical exit: 15 Nov 2023 (T+90)
48,373 shares@ US$5.4616.7% of flowCommon StockSEC:0000921895-23-001485:0
20,000 shares@ US$2.673.4% of flowCommon StockSEC:0000921895-23-000690:0
Canonical exit: 12 Jun 2023 (T+90)
353,140 shares0Common StockSEC:0000921895-23-000668:0
24,187 shares@ US$2.553.9% of flowCommon StockSEC:0000921895-23-000012:0
15,000 shares@ US$2.412.4% of flowCommon StockSEC:0000921895-22-003154:0
Canonical exit: 28 Feb 2023 (T+90)
40,000 shares@ US$3.198.5% of flowCommon StockSEC:0000921895-22-002497:0
Canonical exit: 15 Nov 2022 (T+90)
92,771 shares@ US$3.9024.2% of flowCommon StockSEC:0000921895-22-002223:0
30,000 shares@ US$3.710.36% mcap2.9% of flowCommon StockSEC:0000921895-22-002024:0
Canonical exit: 13 Sept 2022 (T+90)
48,373 shares@ US$3.950.60% mcap4.9% of flowCommon StockSEC:0000921895-22-001986:0
30,000 shares@ US$3.780.36% mcap2.9% of flowCommon StockSEC:0000921895-22-001555:0
Canonical exit: 4 Aug 2022 (T+90)
157,037 shares0Common StockSEC:0001193805-22-000419:0
47,424 shares@ US$7.0513.9% of flowCommon StockSEC:0000921895-22-000032:0
24,187 shares@ US$7.277.3% of flowCommon StockSEC:0000921895-21-002905:0
13,777 shares0Common StockSEC:0000921895-21-002678:0
48,175 shares@ US$8.0215.5% of flowCommon StockSEC:0000921895-21-002200:0
107,803 shares@ US$8.0334.4% of flowCommon StockSEC:0000921895-21-001842:0
25 of 31 declarations
About Green James W
Green James W is President-CEO. He has 31 filings in total, and across the recent sample of 31 filings, the buy and sell amounts are EUR 608332 and EUR 484380, over the period from 2016-01-05 to 2025-08-19. The companies listed are Harvard Bioscience INC, HARVARD BIOSCIENCE INC and ANALOGIC CORP, and the most common transaction nature is Tax withholding.
